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Abstract  
Rationale, aims and objectives: Patient preferences, increasingly solicited as part of person-centered healthcare 
approaches, are an important part of optimizing the pharmacological treatment of osteoarthritis (OA). Recent choice 
experiments have explored this issue using two types of conjoint analysis: choice-based conjoint analysis (CBCA) and 
adaptive conjoint analysis (ACA). The aim of this study was to examine the feasibility of using adaptive choice-based 
conjoint analysis (ACBCA) methods to determine patient preferences for pharmacological treatment of OA. The specific 
outcomes were patient evaluations of a) 8 attributes in an ACBCA task, b) the computer skills required to complete the task 
and c) the perceived utility of the results. 
Method: Participants were drawn from members of a Research Users’ Group (RUG) who had been diagnosed with OA. 
Participants took part in 2 feasibility studies. In the first feasibility study, 4 RUG members critically examined the 
implementation of a computerized ACBCA task. In the second feasibility study, 11 RUG members completed an ACBCA 
task on medication preferences for osteoarthritis. The ACBCA task was evaluated by a set of self-completed questions and 
through semi-structured interviews. 
Results: The first feasibility study helped to shape the design and contents of the ACBCA task. In the second feasibility 
study, no participants reported the ACBCA task to be hard to read or understand. Most participants agreed that the task 
adjusted appropriately as the session proceeded and that it helped them in making decisions about preferences. Older 
patients and those with little computer experience appeared to find no substantial challenges in using this interactive 
computer-based technique. 
Conclusions: These studies indicate that, with the involvement of patients, face and content validity of an ACBCA task can 
be achieved through a developmental process taking account of participants’ requirements. We advance our study as an 
important contribution to the person-centered healthcare literature. 
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Introduction 
 
Conjoint analysis (CA) is a form of discrete choice 
analysis developed by the marketing industry to elicit 
consumer preferences for products or services [1] and 
encompasses a range of techniques to determine the 
relative importance of the attributes underlying consumer 
preferences. Recently, choice experiments have been used 
in healthcare settings [2,3]. In 2000, however, Ryan and 
Farrer highlighted issues of reliability and validity when 
using CA in health services research [2]. In the last ten 
years, a number of studies have used CA to explore patient 
preferences, an important consideration in the person-
centered approach to therapy, in the pharmaceutical 
treatment of osteoarthritis (OA) [4-9].  
CA assumes that patient preference is determined by a 
range of attributes and that each attribute has a number of 
levels. Tablet choice, for example, may be based on 3 
attributes: colour, size and frequency of administration. 
Taking frequency as an example attribute, possible levels 
could be once a day, more than once a day, only when 
needed. Two features of CA are useful in establishing 
patients’ treatment preferences. First, CA determines the 
relative importance of the presented attributes and levels 
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for each individual. Second, CA shows what attributes 
patients are willing to trade off; for example, they may 
prefer larger tablets because they do not need to take them 
so frequently.  
OA is a common long-term condition of stiff painful 
joints with a variable course of recurrent or persistent pain, 
for which a range of medications may be considered. In 
studying patient preferences in the pharmaceutical 
treatment of OA [4-9], the attributes included need to 
encompass treatment characteristics, benefits, 
complications and (in some healthcare systems) costs. 
However, the greater the number of attributes, the greater 
the complexity of the CA task. Traditional methods of CA, 
which ask patients to rate or rank particular attributes, have 
been expanded to include adaptive techniques, which 
reduce the complexity of the task by adapting questions 
according to the initial answers given by the individual 
patient. This can allow a larger number of attributes to be 
incorporated. In a study of OA, for example, adaptive 
conjoint analysis (ACA) was used to examine medication 
preferences and was able to accommodate up to 7 
attributes [4-6]. The researchers concluded, however, that 
inclusion of more attributes - such as renal toxicity 
associated with non-steroidal anti-inflammatory drugs 
(NSAIDs) - would reduce the validity of the task.  
More recently, choice-based methods (rather than 
techniques based on rating or ranking) have been 
developed to provide more flexibility. In particular, the 
adaptive choice-based conjoint analysis (ACBCA) 
technique contains elements from 2 earlier forms of CA - 
ACA (as described above) and choice-based conjoint 
analysis (CBCA) [10] - and combines both adaptation of 
each scenario based on a respondent’s earlier choices 
(from ACA) and the use of choice rather than ranking of 
scenarios (from CBCA). This combination potentially 
allows more attributes to be considered [11]; as noted 
above, this is a key consideration in relation to the 
pharmaceutical treatment of OA.  
As the use of ACBCA in the study of patient 
medication preferences has not yet been reported, the aim 
of this study was to examine its feasibility in patients with 
OA, most of whom will be in the older age strata of the 
population. The specific outcomes were patient evaluations 
of: a) 8 attributes in a choice task; b) the computer skills 
required to complete the task and c) the perceived utility of 
the results. 
Materia ls and methods 
First  feasibility study 
Background 
This phase involved presenting an ACBCA task to 
members of a research users’ group (RUG) in a research 
centre who have OA. The principle of involving RUG 
members in this stage was that they would be participants 
who were representative of potential users of the software 
for discrete choice experiments and shared decision-
making regarding OA medication in clinical practice.  
All participants were diagnosed with OA and reported 
experiencing one or more of hip, knee, hand, or foot joint 
pain in the past 12 months. Twelve members of the RUG 
were contacted by telephone and invited to attend one 
group session. Available members were sent postal 
invitations, explaining the aims and agenda of the session. 
The final sample comprised 4 participants (2 female, 2 
male).  
The specific objectives were: a) to investigate the 
clarity of the ACBCA question formats; b) to determine 
the amount of information that participants needed to 
understand the ACBCA task and c) to investigate ways to 
improve the design and wording of the ACBCA task. In 
this phase of the study, the choices did not relate 
specifically to medication preferences as we had not yet 
developed these. A more general task was chosen that 
aligned with other research in the Centre and included 6 
attributes and 15 levels relating to OA patients’ 
preferences for consulting a general practitioner (GP). 
Method 
The ACBCA task was presented to the RUG on a laptop 
connected to a projector. A volunteer from the group 
completed the task while other group members watched 
the process via the projector. The volunteer was asked to 
discuss each question while completing the task. An open 
discussion between the volunteer, the remaining group 
members and the researchers, took place after each 
ACBCA screen. Structured probing questions were asked 
after each ACBCA screen. The probing questions were 
broad and general; for example, What do you understand 
by this screen?; How easy or difficult did you find 
completing this question?; How might this be improved? 
Development phase for ACBCA medicat ion task   
ACBCA software (Sawtooth Software, SSI Web, version 
8) was used to develop the discrete choice task. The 
process for constructing the task followed the protocol 
developed by Ryan and Farrar [1]. 
Stage 1 of this phase involved identification of the 
attributes and Stage 2 involved assigning levels to the 
attributes. For these 2 Stages, potential attributes and levels 
for inclusion were identified by a literature search. The 
final list was determined by discussion between members 
of the research team. Stage 3 involved the selection of 
choices to be made. In the ACBCA task, the choice of 
scenarios is defined by the software, based on participants’ 
initial ratings of attributes and levels. The number of 
questions required for the ACBCA task depends on 
respondents’ evaluation of the scenarios. On completion of 
the task, regression analyses (within the software package) 
were used to determine individual preference measures. 
 
 
 
 
European Journal for Person Centered Healthcare 2015 Volume 3 
 
 
 
255 
Second feasibility study  
Background 
Having established key design issues for an ACBCA task 
in feasibility Study 1 and the content, attributes and levels 
of the OA medication task in the development phase, the 
next phase (feasibility Study 2) involved a practical 
ACBCA experiment.  
Method 
Twelve members of the RUG were invited to participate. 
The final sample comprised 11 participants (7 female 
[64%], 4 male [36%]). None had taken part in the first 
feasibility Study. 
Participants were invited individually to complete the 
ACBCA task on a computer in the computer laboratory at 
the Arthritis Research UK Primary Care Centre at Keele 
University, UK. Each respondent had a unique ID number 
and password to complete the task and the time that each 
participant took to complete the task was recorded.  
Immediately after completion of the ACBCA task, 
each participant was asked to complete a feedback form 
about their experience. The form included 9 questions 
relating to the ACBCA task (See Table 1). Responses to 
the questions were in the form of a 5-point Likert scale (1 - 
strongly agree, 2 - agree, 3 - neither agree nor disagree, 4 - 
disagree and 5 - strongly disagree). Participants were then 
individually provided with feedback of the results 
generated by the ACBCA software regarding their personal 
preferences and were invited to discuss in a semi-
structured interview format with the project researcher 
(BAO) the extent to which these results reflected their 
personal preferences.  
 
Table 1 List  of questions in the post task 
evaluat ion. Responses to the questions w ere in 
the form of a  5-point  Likert  scale (1  Strongly 
agree, 2  Agree, 3  Neither agree nor disagree, 4  
Disagree and 5 Strongly disagree) 
 
1. I found the first few screens on which I had to make choices 
    about medications hard to understand. 
  
2. After a few more of these screens I felt comfortable 
    completing the questionnaire.  
 
3. I found the questionnaire easy to read.  
 
4. I found the questionnaire easy to understand.  
 
5. I felt that the questionnaire was adjusting the questions 
    according to my previous answers.  
 
6. I enjoyed completing the questionnaire.  
 
7. Completing the questionnaire helped me in making a decision 
    about my preferences.  
 
8. I prefer to use a pen and paper questionnaire. 
 
9. I would be happy to complete a similar computerized  
   questionnaire in the future. 
Ethical statement  
All participants in this project were members of the 
extended Patient and Public Involvement Group of the 
Arthritis Research UK Primary Care Centre at Keele 
University, UK. These members all signed an agreement to 
use their expertise in the development of research. The 
study complied with Keele University, UK guidelines for 
the storage of sensitive and confidential data on laptops. 
Results 
First  feasibility study 
The results of this study are presented in terms of the 3 
issues outlined in the Methods section.  
To determine the amount of information that 
participants needed to understand the ACBCA task. The 
RUG members reported that there was too much 
information on the screening question pages. For example, 
Respondent 3 stated:  
 
“The difficulty is keeping every one of those 6 factors in 
your head at the same time when also you’ve been given 3 
different sets of circumstances. So, for example, you are 
looking at less pain and you think to yourself, well I 
wouldn’t go to the doctor if I had less pain and then you 
say well there’s a lot of information down here and you see 
a different GP and you go to that one, forgetting that 
you’ve decided beforehand that you wouldn’t go down that 
column.” 
 
To investigate the clarity of the ACBCA question 
formats. The RUG respondents suggested that more 
information in the questions and fewer words in the 
scenarios representing the answers, could make the task 
easier to complete. For example, Respondent 1 stated:  
 
“It [is] just the question itself. It’s [understanding] what are 
you getting at? We had it explained to us, but anybody else 
would need more information.” 
 
To investigate ways to improve the design and wording 
of the ACBCA task. The group discussion resulted in 
substantial changes to the style and presentation of the 
software-generated scenarios. Examples of these changes 
included: better and more substantial information in order 
to clearly explain the process; reduction in the volume of 
information on each screen and changes in the wording on 
screens. For example, Respondent 4 stated:  
 
“The instructions need to be a bit fuller, I think. For each 
one indicate whether it is a possibility or not by choosing 
from the 2 [options] at the bottom of each of the 4 columns. 
It could probably be simplified beyond that.” 
 
In conclusion, the RUG involvement in this session 
helped to shape the design and contents of the ACBCA 
task in preparation for the second feasibility study. 
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Table 2 List  of sources of attributes assigned to the ACBCA task  
 
Attributes in the review studies 
 
Study attributes  (decisions with expert and patient 
groups) 
Label: Fraenkel et al., 2004 [4-6] 
 
Availability 
Route of administration: Fraenkel and Fried, 2008 [7] 
 
Route of administration 
Route of administration: Fraenkel et al., 2004 [4-6] 
 
Frequency 
Percentage of patients who benefit: Fraenkel et al., 2004 [4-6] 
Improved strength: Fraenkel and Fried, 2008 [7] 
Decrease in pain: Fraenkel and Fried, 2008 [7] 
 
Expected percentage of benefit 
Risk of ulcer: Fraenkel et al., 2004 [4-6]; Chang et al., 2005 [9]  Fraenkel 
and Fried, 2008 [7]  
 
Risk of gastric ulcer 
Risk of serious side effects: Ratcliffe et al., 2004 [8] Risk of addiction 
Risk of renal and liver impairment 
Risk of heart attacks and strokes 
 
Table 3 The levels of the  attributes and their sources 
 
Attribute Levels Source 
Availability 
 
1. Prescription drug Fraenkel et al., 2004 [4-6] 
2. Over-the-counter drug Fraenkel et al., 2004 [4-6] 
3. Internet purchase drug Discussions with expert and patient groups 
Route of administration 
 
1. Cream/Gel Fraenkel and Fried, 2008 [7] & Fraenkel et 
al., 2004 [4-6] 
2. Oral Fraenkel et al., 2004 [4-6] 
Frequency 
 
1. Once a day Fraenkel et al., 2004 [4-6] 
2. Twice a day Fraenkel et al., 2004 [4-6] 
3. 3-4 times a day Fraenkel et al., 2004 [4-6] 
4. As needed Discussions with expert and patient groups 
Expected percentage of benefit 
 
1. Expect 25% benefit Fraenkel et al., 2004 [4-6] 
2. Expect 50% benefit Fraenkel et al., 2004 [4-6] 
3. Expect 75% benefit Fraenkel et al., 2004 [4-6] 
Risk of gastric ulcer 
 
1. No risk Discussions with expert and patient groups 
2. Low risk Discussions with expert and patient groups 
3. Moderate risk Discussions with expert and patient groups 
4. High risk Discussions with expert and patient groups 
Risk of addiction 
 
1. No risk Discussions with expert and patient groups 
2. Low risk Discussions with expert and patient groups 
3. Moderate risk Discussions with expert and patient groups 
4. High risk Discussions with expert and patient groups 
Risk of kidney and liver impairment 
 
1. No risk Discussions with expert and patient groups 
2. Low risk Discussions with expert and patient groups 
3. Moderate risk Discussions with expert and patient groups 
4. High risk Discussions with expert and patient groups 
Risk of heart attacks and strokes 
 
1. No risk Discussions with expert and patient groups 
2. Low risk Discussions with expert and patient groups 
3. Moderate risk Discussions with expert and patient groups 
4. High risk Discussions with expert and patient groups 
 
Development phase  
This was the outcome of a systematic review in which 5 
previous studies of the use of CA in relation to OA 
patients’ treatment preferences were identified [4-9,12]. 
The attributes identified by these studies were placed in 6 
categories: 1. OA characteristics such as pain severity; 2. 
Treatment characteristics such as route of administration; 
3. Treatment benefits; 4. Treatment complications; 5. 
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Route and frequency of administration and 6. Costs (cost 
was not included in our study among older UK patients 
because cost of medications for older persons in the UK 
healthcare system is rarely a direct issue). Based on the 
literature, discussions within the research team and 
feedback from RUG participants in the first feasibility 
Study, a list of attributes and levels was finalized (see 
Tables 2 and 3). 
Second feasibility study 
Eleven participants (4 male [36%] and 7 female [64%]) 
with OA in one or more of the hips, knees, shoulders, 
hands, ankles and spine took part in this study. All 
participants were over 50 years of age. Most (73%) had 
lived with OA for over 5 years. All participants reported 
that joint pain affected their normal life; 9 (82%) reported 
it affected them moderately to extremely. The participants 
reported using paracetamol (82%), NSAIDs and COX-2 
inhibitors (82%), opioids (64%) and glucosamine (64%) 
for the management of OA as the most commonly used 
drugs.  
All participants completed the ACBCA task. The mean 
time for completing the ACBCA task was 24 minutes, 
ranging from 12 to 48 minutes. The participant who 
completed the task in 48 minutes was an outlier (mean if 
excluded = 22 minutes) who reported specifically taking 
time to critically investigate the task while completing it.  
Participants had diverse computer skills, ranging from 
people who did not use or possess a computer (n=2) to 
those who use a computer daily (n=4). There was no major 
difference in the mean task completion time between 
participants who did not have a computer and other 
participants (20.5 minutes and 24.7 minutes respectively). 
The 2 participants without a computer completed the task 
in 18 minutes and 23 minutes respectively. Furthermore, 2 
participants who had never completed a computerized task 
in the past completed the ACBCA task in 23 and 24 
minutes.  
All participants completed the post-experiment survey 
(see Table 4). Nine participants disagreed or strongly 
disagreed that the first few screens were hard to understand 
(Question 1). Most participants (n=10) agreed or strongly 
agreed that they felt comfortable after completing a few 
screens (Question 2). None of the participants reported the 
ACBCA task to be hard to read or understand (Questions 3 
and 4). Most participants (n=10) agreed that the task was 
adjusting to their individual responses as the task 
proceeded (Question 5). Most participants (n=10) agreed 
that the task helped in making decisions about preferences 
(Question 7). One participant said they would prefer pen 
and paper to the computer (Question 8). All participants 
agreed that they would be happy to complete a similar 
ACBCA task in the future (Question 9). 
When asked in the semi-structured interviews whether 
the results of the task reflected their own preferences, 10 
participants confirmed that this was the case. The 
remaining participant was not sure that the prediction of 
the attribute with the highest relative importance was 
accurate, but agreed with the other results. 
Discussion 
In reviewing the use of CA in health services research, 
Ryan and Farrar outlined a series of steps in constructing 
appropriate tasks [2]. They also noted that “methodological 
issues need further consideration”. This study focused on 
the feasibility of using ACBCA. While ACBCA appears to 
combine the advantages of ACA and CBCA, it may result 
in a task that is too complex for respondents to complete. 
Earlier methods had not been able to include 8 attributes 
and while ACBCA theoretically could include this number 
of attributes, there had been no empirical evaluations of 
specific tasks. In our study, the focus was on the validity of 
an ACBCA task with 8 attributes. The first type of validity 
we examined was face validity: did the task appear to 
evaluate what it aimed to evaluate? This was addressed in 
the first feasibility Study through testing the wording and 
clarity of the questions and in the second feasibility study 
by participants’ perception that the results of the task 
reflected their preferences. The second type of validity was 
content validity: did the task include an appropriate range 
of attributes and levels? This was attained through 
participants’ involvement in finalizing the list of attributes 
and levels in the development phase. This study was not 
concerned with predictive validity (i.e., whether stated 
preferences in the discrete choice experiment were 
reflected in subsequent behaviour) or with reliability (i.e., 
the reproducibility of participants’ responses in a separate 
occurrence of the experiment). While these are important 
concepts, they were beyond the scope of the present study 
[13]. Our measures of validity were dependent on self-
report. 
The first feasibility Study was conducted in a group 
format and identified strengths and limitations of the 
ACBCA task. Regarding the strengths, the consensus was 
that the ACBCA task did not require advanced computer 
skills. Rochon et al. [14] conducted a similar study aiming 
to understand elderly patients’ experiences with the use of 
ACA to explore treatment options for OA. Their results 
suggest that elderly OA participants’ low level of computer 
comfort is a significant contributor to the problematic 
challenge that participants faced when completing ACA 
task [14]. These results differ from the results of this study, 
which suggest that computer skills are not a requirement 
for completing an ACBCA questionnaire. There are 
various possible explanations for these discrepant findings. 
First, participants in Rochon et al. [14] reported that the 
ACA task did not adapt to the preferences they expressed 
during the questionnaire, as opposed to the participants in 
this project who reported that ACBCA task adapted to their 
expressed preferences accordingly. Second, the choice-
based task is more favourable than the rating/ranking task 
[15]. Thus, participants feel more comfortable completing 
the ACBCA questionnaire than completing an ACA 
questionnaire.  
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Table 4 Results of the part ic ipants feedback regarding the ACBC task  
 
Feedback from question Frequency (Percentage) 
Strongly 
agree 
 
Agree 
 
Neither 
agree nor 
disagree 
Disagree 
 
Strongly 
disagree 
I found the first few screens on which I had to make choices about 
medications hard to understand 
 
0 (0) 1 (9.1) 1 (9.1) 6 (54.5) 3 (27.3) 
After a few more of these screens I felt comfortable completing the 
questionnaire 
 
4 (36.4) 6 (54.5) 1 (9.1) 0 (0) 0 (0) 
I found the questionnaire easy to read 
 
7 (63.6) 3 (27.3) 1 (9.1) 0 (0) 0 (0) 
I found the questionnaire easy to understand 
 
5 (45.5) 5 (45.5) 1 (9.1) 0 (0) 0 (0) 
I felt that the questionnaire was adjusting the questions according to 
my previous answers 
 
6 (54.5) 4 (36.4) 1 (9.1) 0 (0) 0 (0) 
I enjoyed completing the questionnaire 
 
3 (27.3) 7 (63.6) 1 (9.1) 0 (0) 0 (0) 
Completing the questionnaire helped me in making a decision about 
my preferences 
 
5 (45.5) 3 (27.3) 3 (27.3) 0 (0) 0 (0) 
I prefer to use a pen and paper questionnaire 
 
0 (0) 1 (9.1) 5 (45.5) 4 (36.4) 1 (9.1) 
I would be happy to complete a similar computerised questionnaire 
in the future 
7 (63.6) 4 (36.4) 0 (0) 0 (0) 0 (0) 
 
 
In another study investigating the feasibility and 
reliability of ACA as an assessment tool for individual 
patient preferences, 2 of the 50 participants completing a 
computerized ACA questionnaire started the exercise, but 
discontinued it because they found it too difficult [16]. The 
group also reported that the interactive element of the task 
resulted in a greater sense of involvement. The main 
limitations identified related to the construction of 
attributes and levels and the lack of clarity of the format of 
the questions. Following the first feasibility Study - which, 
as noted above, was limited to 6 attributes and did not 
focus on medication preferences - the OA medication task 
was developed and designed using the latest version of the 
ACBCA software (SSI Web 7.0.26). While this task 
incorporated the feedback from the first feasibility Study, it 
also involved a completely new task focused on 
medication preferences. 
The results of the second feasibility Study indicate that 
8 attributes and levels can be included in an ACBCA task 
on the pharmacological treatment of OA. While this paper 
does not present the results of the task (i.e., the actual 
values for attributes and levels), it establishes that 8 
attributes can be incorporated into an ACBCA task. As 8 
attributes have acceptable face validity, there is potential to 
develop an ACBCA task to include more attributes and test 
it the in the future. Thus, in the present task, only one 
attribute was concerned with medication benefit compared 
to 3 for medication risk. The benefit attributes could be 
split up further into various components (e.g., chance of 
benefit from the treatment and time to benefit) [4]. 
This study evaluated only one ACBCA task and 
further work is needed to examine different ACBCA tasks 
in healthcare settings. Green and Srinivasan [17] reported 
that several studies have demonstrated consistency of CA 
models in terms of reproducing current market conditions 
and customers preferences. To date, research on computer-
based versions of CA indicate satisfactory validity, 
although this issue has not been analysed in depth (see 
http://www.conjointanalysis.net/CANet/Manuskripte/Valid
ityOCA.pdf).  
The strengths of the feasibility study designs were that 
all participants were individuals with OA. They were 
taking part as members of a group that had an established 
mandate to be critical, but constructive participants in 
helping to develop robust research methods that would 
engage all types and backgrounds of future participants. 
They had particular experience in ensuring that the 
language of material presented to them was accessible and 
easy to follow and in highlighting anything in the research 
process that might be difficult to do or to understand. The 
RUG participant samples were different for feasibility 
Studies 1 and 2 to ensure independence of the 2 stages. 
The samples, although small, proved sufficient for the 
purposes of each study.  
The limitations of our study include the fact that the 
second feasibility Study tested one particular set of 
attributes and levels in a controlled research environment 
with a group of interested participants and its 
generalizability to ACBCA experiments with different, 
larger attribute sets in a ‘real-life’ clinical context remains 
to be demonstrated. Testing of the validity of the 
individual outputs of the ACBCA experiment was limited 
in these studies to questionnaires and interviews; objective 
investigation of whether the outputs represent choices 
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made in practice (predictive validity) and of the usefulness 
of the outputs in supporting ‘real-life’ choices was beyond 
the scope of the studies. However, the studies have 
established both the feasibility of doing such experiments 
in this type and age group of patients and the method of 
developing feasible and practical ACBCA experiments 
through the engagement of patients in the development 
process. They have laid the basis for future research into 
the practical application of ACBCA experiments in 
describing and supporting treatment decisions made in 
real-life situations.  
Although Ryan and Farrar [2] described the process of 
undertaking a CA study as occurring in 5 stages, they did 
not include patient involvement as an aspect in the 
construction of the attributes. Generally, patients have been 
involved in research as “subjects”, but not as part of the 
research team [18]. In recent years, growing attention has 
been paid to engaging patients in research, but the level of 
involvement remains minor and this has important 
implications for the development of person-centered 
healthcare. Barber and colleagues [19] conducted a study 
investigating patients’ involvement in 518 NHS research 
projects and found that only 17% of the researchers 
involved patients as members of the research group. One 
of the key strengths of this study is the involvement of the 
RUG in every step of the research development. The RUG 
members were involved in appraising the ACBCA design, 
evaluating the attributes and levels of the ACBCA task and 
testing the final version of the ACBA task. 
Conclusion  
In conclusion, there is little research into the validity and 
reliability of computerized or online versions of CA [20]. 
This study has highlighted that adequate face and 
measurement validity of an ACBCA task can be achieved 
through a developmental process taking account of 
participants’ requirements. The involvement of participants 
during the design phase of the task enabled the research 
team to construct an ACBCA task that resulted in 
participants reporting that the task helped them to identify 
their medication preferences for the treatment of 
osteoarthritis. We advance our study as an important 
contribution to the person-centered healthcare literature. 
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